These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 20108366)

  • 1. Mixed tremors with integrity of nigrostriatal system: a clinical and DAT-SPECT follow-up study.
    Arabia G; Novellino F; Morelli M; Paglionico S; Salsone M; Giofrè L; Pucci F; Bagnato A; Cascini GL; Nicoletti G; Messina D; Quattrone A
    Mov Disord; 2010 Apr; 25(5):662-4. PubMed ID: 20108366
    [No Abstract]   [Full Text] [Related]  

  • 2. Predictive value of nigrostriatal dysfunction in isolated tremor: a clinical and SPECT study.
    Ceravolo R; Antonini A; Volterrani D; Rossi C; Kiferle L; Frosini D; Lucetti C; Isaias IU; Benti R; Murri L; Bonuccelli U
    Mov Disord; 2008 Oct; 23(14):2049-54. PubMed ID: 18759337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for pre and postsynaptic nigrostriatal dysfunction in the fragile X tremor-ataxia syndrome.
    Healy DG; Bressman S; Dickson J; Silveira-Moriyama L; Schneider SA; Sullivan SS; Massey L; Bhatia KP; Shaw K; Bhatia KP; Bomanji J; Wood NW; Lees AJ
    Mov Disord; 2009 Jun; 24(8):1245-7. PubMed ID: 19260103
    [No Abstract]   [Full Text] [Related]  

  • 4. Nigrostriatal dopaminergic function in subjects with isolated action tremor.
    Coria F; Gimenez-Garcia M; Samaranch L; Mora FJ; Sampol-Bas C; Pastor P
    Parkinsonism Relat Disord; 2012 Jan; 18(1):49-53. PubMed ID: 21917500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive-nigrostriatal relationships in de novo, drug-naïve Parkinson's disease patients: a [I-123]FP-CIT SPECT study.
    Nobili F; Campus C; Arnaldi D; De Carli F; Cabassi G; Brugnolo A; Dessi B; Morbelli S; Sambuceti G; Abbruzzese G; Rodriguez G
    Mov Disord; 2010 Jan; 25(1):35-43. PubMed ID: 20058228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPECT study of the nigrostriatal dopaminergic system in Huntington's disease.
    Hwang WJ; Yao WJ
    J Neuroimaging; 2013 Apr; 23(2):192-6. PubMed ID: 22211920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of dopamine transporter imaging with parkinsonian motor handicap: how close is it?
    Pirker W
    Mov Disord; 2003 Oct; 18 Suppl 7():S43-51. PubMed ID: 14531046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of dopamine transporter imaging in the diagnosis of atypical tremor disorders.
    Marshall V; Grosset DG
    Mov Disord; 2003 Oct; 18 Suppl 7():S22-7. PubMed ID: 14531042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nigro-striatal involvement in primary progressive freezing gait: insights into a heterogeneous pathogenesis.
    Fasano A; Baldari S; Di Giuda D; Paratore R; Piano C; Bentivoglio AR; Girlanda P; Morgante F
    Parkinsonism Relat Disord; 2012 Jun; 18(5):578-84. PubMed ID: 22459564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine transporter: basic aspects and neuroimaging.
    Piccini PP
    Mov Disord; 2003 Oct; 18 Suppl 7():S3-8. PubMed ID: 14531039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [123I]FP-CIT striatal binding in early Parkinson's disease patients with tremor vs. akinetic-rigid onset.
    Isaias IU; Benti R; Cilia R; Canesi M; Marotta G; Gerundini P; Pezzoli G; Antonini A
    Neuroreport; 2007 Sep; 18(14):1499-502. PubMed ID: 17712282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined use of DAT-SPECT and cardiac MIBG scintigraphy in mixed tremors.
    Novellino F; Arabia G; Bagnato A; Cascini GL; Salsone M; Nicoletti G; Messina D; Morelli M; Paglionico S; Giofrè L; Restuccia A; Torchia G; Condino F; Quattrone A
    Mov Disord; 2009 Nov; 24(15):2242-8. PubMed ID: 19795467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nigrostriatal pathway dysfunction in a methanol-induced delayed dystonia-parkinsonism.
    Franquet E; Salvadó-Figueres M; Lorenzo-Bosquet C; Cuberas-Borrós G; Rovira A; Castell-Conesa J; Hernandez-Vara J
    Mov Disord; 2012 Sep; 27(10):1220-1. PubMed ID: 22976778
    [No Abstract]   [Full Text] [Related]  

  • 14. [Study of presynaptic nigrostriatal pathway by 123-I-FD-CIT-SPECT (DatSCAN SPECT) in primary orthostatic tremor].
    Vaamonde J; García A; Flores JM; Ibáñez R; Gargallo L
    Neurologia; 2006; 21(1):37-9. PubMed ID: 16525925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac denervation precedes nigrostriatal damage in idiopathic rapid eye movement sleep behavior disorder.
    Salsone M; Labate A; Quattrone A
    Mov Disord; 2012 Jul; 27(8):1068-9. PubMed ID: 22605537
    [No Abstract]   [Full Text] [Related]  

  • 16. Anterograde Degeneration of the Nigrostriatal Pathway Visualized by 123I-FP-CIT SPECT in a Patient With Artery of Percheron Infarction.
    Nakadate M; Miyamoto N; Starkey J; Toriihara A; Tateishi U
    Clin Nucl Med; 2016 Jun; 41(6):483-4. PubMed ID: 26914571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine transporter imaging study in parkinsonism occurring in fragile X premutation carriers.
    Ceravolo R; Antonini A; Volterrani D; Rossi C; Goldwurm S; Di Maria E; Kiferle L; Bonuccelli U; Murri L
    Neurology; 2005 Dec; 65(12):1971-3. PubMed ID: 16380622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher nigrostriatal dopamine neuron loss in early than late onset Parkinson's disease?--a [99mTc]-TRODAT-1 SPECT study.
    Shih MC; Franco de Andrade LA; Amaro E; Felicio AC; Ferraz HB; Wagner J; Hoexter MQ; Lin LF; Fu YK; Mari JJ; Tufik S; Bressan RA
    Mov Disord; 2007 Apr; 22(6):863-6. PubMed ID: 17290452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced striatal [123 I]FP-CIT binding in SCA2 patients without parkinsonism.
    Varrone A; Salvatore E; De Michele G; Barone P; Sansone V; Pellecchia MT; Castaldo I; Coppola G; Brunetti A; Salvatore M; Pappatà S; Filla A
    Ann Neurol; 2004 Mar; 55(3):426-30. PubMed ID: 14991822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nigrostriatal involvement in ataxia with oculomotor apraxia type 1.
    Salvatore E; Varrone A; Criscuolo C; Mancini P; Sansone V; Strisciuglio C; Cicala D; Scarano V; Salvatore M; Pappatà S; De Michele G; Filla A
    J Neurol; 2008 Jan; 255(1):45-8. PubMed ID: 18004640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.